Research Insight
Phase 3 PROSPER Trial Shows XTANDI Significantly Reduced the Risk of Metastasis or Death by 71 Percent in Men with Non-Metastatic Castration-Resistant Prostate Cancer
Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko Hatanaka, “Astellas”) and Pfizer Inc. (NYSE: PFE) announced today results from the Phase 3 PROSPER...
News
Deepak Nath Head of Laboratory Diagnostics at Seimens
Siemens Healthineers has appointed Dr. Deepak Nath as President of Laboratory Diagnostics effective February 1. Nath succeeds Franz Walt, who served as President from...
Press Releases
Making Ultrasound More Accessible: GE Healthcare’s New Versana Essential Combines Quality and Affordability
Helping clinicians expand diagnostic capabilities and increase patient satisfaction, GE Healthcare today unveiled a new ultrasound system with impeccable image quality and advanced yet...
Research Insight
Leading Advances in Transplant Medicine
NYU Langone has assembled a team dedicated to cutting-edge research, to reinforce and energize the Transplant Institute’s commitment to world-class care. Dr. Kon, who...
Press Releases
NYU Langone Health Launches New Lung Transplant Program
NYU Langone’s Transplant Institute has launched a new lung transplant program, the third program of its kind in the greater New York City area,...
Press Releases
Mount Sinai Health System Expands Innovative Care in Florida
Mount Sinai Health System in New York announced the opening of a new state-of-the-art medical practice in Palm Beach, Florida, bringing world-class, innovative care...
Articles
CPhI India 2017 – Essentra interview
1. You have recently showcased the Golden Ratio pack can you brief us about it?
Showcased at Luxe Pack 2017 and inspired by Autumn/Winter 2018...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read